top of page

Innovation in Private Equity Using Structured Financial Products

  • Writer: PrimeAlpha Thought Leadership
    PrimeAlpha Thought Leadership
  • May 8, 2020
  • 2 min read

Updated: Mar 18

Innovation in Private Equity Using Structured Financial Products


High Growth, High Return Alternative Assets While Collateralizing the Principal


A structured financial product known as VICAN allows investors to engage with alternative asset investments while protecting their principal. This investment vehicle is divided into two parts: the first targets equity investments in mid-market acquisitions, early-stage technology, life sciences, and real estate projects, aimed at growth. The second part involves conservative investments in zero-coupon bonds, banks, and insurance products, designed to return the principal after a 7 to 10-year term.


VICAN is based on structured notes, sophisticated hybrid securities that combine elements of bonds and equities. These notes, managing approximately $2 trillion in global assets, are especially popular in Asia and Europe. They are crafted to reflect the performance of underlying assets such as stock indices or commodities, offering profit participation with a level of loss protection, making them an appealing option for risk-managed investment in alternative assets.


Access the entire article to explore the innovative VICAN investment structure in detail. Discover how it combines growth potential with principal protection in the dynamic field of alternative asset investments. Dive deeper into how structured notes work, their global market presence, and their role in managing investment risks.



If you do not have a work email address, please email us at info@primealpha.com and we can email you the report directly.



Table of Contents

  • What are Structured Notes

  • Alternative Assets Offer Superior Return Opportunities

  • Democratizing Access: VICAN

  • Why VICAN? Add Equity Upside with Principal Protection to Your Portfolio

  • An Application of VICAN: United Cancer Centers




Thanks to our Contributor


Vivaris Capital Logo


Vivaris Capital is an established private equity group with more than 25 years of experience that’s focused on successful investments in alternative assets. Vivaris Capital aligns its interests with those of the investors with the goal to maximize their return on investment. As such, it does not charge any fees based on assets under management (AUM). Vivaris Capital creates value by driving operational performance, realizing increasing scale, aligning strategically with acquirers, and through financial engineering. The VICAN structure has transformed how the company invests and manages risk. They work to share it with investors who want to reduce the risk of loss on equity investments, increase yields compared to investment grade fixed income investments, and support mission-based investors.

Access PrimeAlpha
Alternatives Education, Research, Database of Managers and Investors

​Important Disclaimers
This article (the “Article”) is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to purchase any investment or any securities. This Article does not constitute investment advice and is not intended to be relied upon as the basis for an investment decision, and is not, and should not be assumed to be, complete. Readers should make their own investigations and evaluations of the information contained herein. The information contained herein does not take into account the particular investment objectives or financial circumstances of any specific person or entity who may receive it. Each reader should consult its own attorney, business adviser and tax adviser as to legal, business, tax and related matters concerning the information contained herein.  Except where otherwise indicated herein, the information provided herein is based on matters as they exist as of the date of preparation and not as of any future date and will not be updated or otherwise revised to reflect information that subsequently becomes available, or circumstances existing or changes occurring after the date of preparation. Certain information contained in this Article constitutes “forward-looking statements,” which can be identified by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,”  “target,” “project,” “estimate,” “intend,” “continue” or “believe,” or the negatives thereof or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results may differ materially from those reflected or contemplated in such forward-looking statements. Readers should not rely on these forward-looking statements.  Certain information reflects subjective determinations which may prove to be incorrect. There can be no assurance that the estimates or projections will be accurate or that historical trends will continue. In considering the prior performance information contained herein, readers should bear in mind past performance is not necessarily indicative of future results. All rights reserved. The material may not be reproduced or distributed, in whole or in part, without the prior written permission of PrimeAlpha LLC.

bottom of page